Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-25-001822
Filing Date
2025-05-15
Accepted
2025-05-15 10:15:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14720
  Complete submission text file 0000930413-25-001822.txt   16362
Mailing Address 2 OVERHILL ROAD SCARSDALE NY 10583
Business Address 2 OVERHILL ROAD SCARSDALE NY 10583 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Subject) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91895 | Film No.: 25949650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)